Community-acquired pneumonia due to S. aureus

S. Ozsari, P. Sarac, M. S. Tasbakan, A. Sayiner (Izmir, Turkey)

Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session: Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session type: Thematic Poster Session
Number: 2465
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ozsari, P. Sarac, M. S. Tasbakan, A. Sayiner (Izmir, Turkey). Community-acquired pneumonia due to S. aureus. Eur Respir J 2011; 38: Suppl. 55, 2465

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009



Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010



Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006

Community-acquired pneumonia
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Community-acquired pneumonia
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Community-acquired pneumonia
Source: International Congress 2019 – Part I: Prevention and management of respiratory infections in primary care.
Year: 2019


MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009



Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007

Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002



MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009


Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 608s
Year: 2002

Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008



Severe Chlamydia pneumoniae community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003

An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Source: Eur Respir J 2010; 36: 901-906
Year: 2010



Community-acquired pneumonia due to streptococcus pneumoniae in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Community-acquired pneumonia in children
Source: Annual Congress 2012 - PG15 Common respiratory infections in childhood: current guidelines and controversies
Year: 2012



Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020